Stock Taper 
LYEL
$14.53
▼ DOWN 0.55% (-0.08)
KEY STATISTICS
Market Cap$356.05 M
52w High$45.00
52w Low$10.76
Dividend Yield—
Frequency—
P/E-1.05
Volume78.12K
Shares Out.24.50M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Lynn Seely
COMPENSATION 2026
Salary$690,173
Stock Awards$186,806
Incentive Plan Pay$414,000
All Other Comp.$23,735
Total$4,222,265
ABOUT
SECTOR
Healthcare
WENT PUBLIC
June 17, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
161
PRICE TARGET
Target High$49.00
Target Low$34.00
Target Median$45.00
Target Consensus$42.67
UPCOMING EARNINGS
DateNov 10, 2026
DayTuesday
Rev. Est.$3.83K
NOV
10
TUE
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-06-02 | Reverse | 1:20 |
PRICE
$14.53 ▼ DOWN 0.55% (−$0.08)About Lyell Immunopharma, Inc.
https://www.lyell.com ↗Lyell Immunopharma develops T cell therapies for solid tumors using genetic and epigenetic reprogramming technologies, with pipeline candidates targeting cancers like lung, breast, and synovial sarcoma.
INDUSTRY
Biotechnology
A PRODUCT LYELL IMMUNOPHARMA, INC. IS KNOWN FOR
Ronde-cel (LYL314)
A clinical-stage, dual-targeting CD19/CD20 CAR T-cell therapy for patients with large B-cell lymphoma. As Lyell Immunopharma's lead product candidate, it represents their most advanced and prominent offering currently in pivotal clinical trials.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Reportable segment | $15K | $6K ▼ | $2K ▼ | $4K ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
66
LISTED HERE
10
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
100.00%
HOLDERS
96
TOP 12 OF 96 · RANKED BY POSITION SIZE
Apoletto Ltd
Blackrock Inc.
Wuxi Apptec Co., Ltd.
Arch Venture Management, LLC
Gsk Plc
Mic Capital Partners (Public) (Us) Im, LLC
Mwg Management Ltd.
Vanguard Group Inc
Foresite Capital Management Iv, LLC
Orland Properties Ltd
Nuveen Asset Management, LLC
Almitas Capital LLC
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book4
Overall Score2
INSIDER TRADES
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Seely Lynn
Sale · 9.6K shares
2026-08-21
★
OFFICER: CHIEF OPERATING OFFICER
Hill Stephen J.
Sale · 989 shares
2026-08-21
★
OFFICER: CHIEF SCIENTIFIC OFFICER
Lee Gary K.
Sale · 1.5K shares
2026-08-21
★
OFFICER: VP, CORPORATE CONTROLLER
Bulis Veronica Sanchez
Sale · 621 shares
2026-08-10
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
MARKET OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ALLO | $2.02 | COMPARE |
 SLN | $13.42 | COMPARE |
 KYTX | $8.37 | COMPARE |
 CABA | $3.12 | COMPARE |
 EDIT | $3.16 | COMPARE |
 LRMR | $4.01 | COMPARE |
 AMRN | $13.97 | COMPARE |
 ACIU | $2.65 | COMPARE |